How Lunula Laser Works
The Commitment to Research
Since 1996, Erchonia, the manufacturer of Lunula, has been committed to fully elucidating the medical utility of low-level laser therapy through rigorous clinical studies. For over a decade, Erchonia has studied the clinical utility of low-level laser devices for the treatment of numerous medical ailments, and their recent device, Lunula, looks to revolutionise the way the medical community treats onychomycosis.
Lunula has been markedly studied – from the early in-vitro analysis to the extensive in-vivo studies – and its clinical utility to treat painful and unsightly toenail infections has been substantiated. The unique dual-diode approach of Lunula effectively targets the causative infectious agent while fortifying the body’s natural defense mechanisms. This multifaceted approach is the first of its kind, providing patients with a truly effective, yet safe, treatment for onychomycosis.
As you will quickly learn, Lunula is supported by an unwavering clinical foundation of both histological and clinical evidence that upholds the viability of this approach and ensures an effective treatment for patients suffering with onychomycosis.
Lunula Safely treats toenail fungus in only four 12-minute painless treatments!
Lunula's Proven Approach
Lunula combines two therapeutically beneficial wavelengths: 405 and 635nm. Each wavelength is capable of stimulating a specific cascade to effectively and safely treat onychomycosis. Both wavelengths are enriched by a proprietary, rotating line-generated beam; a unique delivery mechanism that maximises photon concentration and treatment surface area— ensuring that all infected toes are properly treated. As a result, the Lunula provides a treatment absent of any adverse events while inducing key pathways to effectively address unsightly onychomycosis.
The 635nm wavelength stimulates cytochrome c oxidsase (CCO), an important enzyme necessary for the production of adenosine triphosphate (ATP) and reactive oxygen species (ROS). Increased ATP activates PI3 kinase/eNOS signaling pathways, which increases nitric oxide (NO) production. NO is critical for new blood vessel formation increasing nutrient delivery and infiltration of immunological cells. Additionally, NO is a powerful antimicrobial agent, and will help destroy the infectious agent. For resident macrophages and neutrophils, two types of immune cells, the increased production of ROS is quickly converted into cytotoxic hydrogen peroxide (H2O2), which is used by the immune cells to destroy onychomycosiscausing fungus.
The 405nm wavelength targets NADPH oxidase (NOX), a membrane bound enzyme, and increases NOX’s production of ROS, which can be converted into H2O2. As H2O2 starts to degrade the fungal cell wall and membrane fungi function and behaviour will be greatly impaired. This can result in fungal death. Additionally, degradation of the fungi membrane and cell wall will increase fungal susceptibility to the body’s immune attack.
Results show that the vast majority of treated patients experience significant improvement and, in most cases, fungal nails are completely clear. Beautiful toenails can be a reality for you!
On average, a toenail will replace itself every 9-12 months. Healthy new
growth should be visible within the first 3 months as your nails continue to grow. The laser treatment will not cause your toenails to discolour or fall off.
For more information on toenail fungus treatment or for an initial consultation, fill out the form on this page. We'll be in contact with you soon!